PAS
ARKG icon

Park Avenue Securities’s ARK Genomic Revolution ETF ARKG Stock Holding History

Park Avenue Securities’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$253K Buy
+6,024
New +$192K ﹤0.01% 1607
2024
Q4 		– Sell
-9,050
Closed -$232K – 1465
2024
Q3 		$232K Sell
9,050
-1,615
-15% -$41.1K ﹤0.01% 1286
2024
Q2 		$250K Sell
10,665
-1,002
-9% -$25.3K ﹤0.01% 1240
2024
Q1 		$336K Buy
11,667
+1,435
+14% +$43.2K ﹤0.01% 1135
2023
Q4 		$336K Buy
10,232
+203
+2% +$5.52K ﹤0.01% 1071
2023
Q3 		$279K Buy
+10,029
New +$328K ﹤0.01% 1078
2023
Q2 		– Sell
-11,611
Closed -$349K – 723
2023
Q1 		$349K Sell
11,611
-2,110
-15% -$65.4K 0.01% 649
2022
Q4 		$387K Sell
13,721
-2,101
-13% -$66.7K 0.01% 874
2022
Q3 		$520K Buy
15,822
+2,139
+16% +$78.5K 0.01% 696
2022
Q2 		$431K Sell
13,683
-940
-6% -$32.9K 0.01% 756
2022
Q1 		$672K Buy
14,623
+373
+3% +$17.8K 0.01% 618
2021
Q4 		$873K Buy
14,250
+7,271
+104% +$503K 0.02% 523
2021
Q3 		$521K Buy
6,979
+4,222
+153% +$354K 0.01% 617
2021
Q2 		$255K Buy
+2,757
New +$234K 0.01% 906

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Park Avenue Securities's ARKG Position: Q2 2026 in Review

Park Avenue Securities opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 6,024 shares worth $253K. The stake represents ﹤0.01% of the portfolio and ranks #1607 among its holdings. This is a return to the name: Park Avenue Securities previously reported a position in ARKG as recently as Q3 2024.

Park Avenue Securities first reported a position in ARKG in Q2 2021 and has held it in 14 quarters since. The position peaked at $873K in Q4 2021. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Park Avenue Securities held 6,024 shares of ARK Genomic Revolution ETF worth $253K as of Q2 2026.
  • ARK Genomic Revolution ETF was a new Park Avenue Securities position in Q2 2026.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Park Avenue Securities's portfolio in Q2 2026, its #1607 holding.
  • Park Avenue Securities first reported a position in ARK Genomic Revolution ETF in Q2 2021 and has held it in 14 quarters since.
  • Park Avenue Securities's ARK Genomic Revolution ETF position peaked at $873K in Q4 2021.
  • 272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.